Insulin resistance and heart failure.

Area of Science:

• Cardiology
• Metabolic Disorders
• Biochemistry

Background:

• Heart failure (HF) is a significant cause of death, with rising prevalence.
• Cardiac energetics and myocardial dysfunction are critical in HF.
• Obesity and type 2 diabetes exacerbate HF through abnormal myocardial metabolism.

Purpose of the Study:

• To explore the complex relationship between heart failure and insulin resistance.
• To identify deranged cardiac metabolism as a potential therapeutic target.
• To emphasize the need for evidence-based, individualized metabolic treatments in HF.

Main Methods:

• Review of clinical studies examining heart failure and metabolic dysfunction.
• Analysis of the impact of obesity and type 2 diabetes on cardiac metabolism.
• Evaluation of existing and potential metabolic therapies for heart failure.

Main Results:

• A complex, interdependent relationship exists between heart failure and insulin resistance.
• Abnormal glucose and fatty acid metabolism in the myocardium are key features.
• Current evidence suggests metabolic treatments may have risks and require careful patient selection.

Conclusions:

• Deranged cardiac metabolism presents a promising therapeutic target for heart failure.
• Metabolic interventions must be individualized and guided by robust clinical trial data.
• Further research is needed to optimize metabolic strategies for heart failure management.